The study demonstrates that guinea-pigs handled daily from birth exhibit similar behaviour to rats on the elevated plus maze. Simultaneously performed intra-cortical microdialysis showed that placing guinea-pigs on the elevated plus maze results in an increase in extracellular 5-HT in the frontal cortex. 8-OH-DPAT (0.3 mg/kg s.c.) reduced significantly the increase in cortical extracellular 5-HT and resulted in an 'anxiolytic' profile of behaviour. Pre-treatment with the 5-HT1 antagonist methiothepin (10.0 mg/kg) antagonized the behavioural effects and prevented the increase in cortical extracellular 5-HT normally produced by exposure to the elevated plus maze. Methiothepin alone had no effect on behaviour in the elevated plus maze. 5-CT (0.1 mg/kg i.p.) abolished the rise in extracellular 5-HT, but did not produce an 'anxiolytic' profile of behaviour on the elevated plus maze. The results show that an increase in cortical extracellular 5-HT occurs in the saline- treated guinea-pig exposed to aversive conditions. It remains to be determined whether the 'anxiolytic' effect of 8-OH-DPAT in the guinea-pig is causally associated with decreased basal extracellular 5-HT. The results however indicate that there is no simple relationship between inhibition of 5-HT release and behaviour indicative of 'anxiolytic' drug actions.
Adrien J., Lanfumey L., Gozlan C., Fattaccini C.M., Hamon M. (1989) Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5- hydroxytryptamine 1A receptors in brain. J Pharmacol Exp Ther248: 1222-1230
2.
Aulakh C.S., Wozniak K.M., Haas M., Hill J.L., Zohar J., Murphy D.L. (1988) Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. Eur J Pharmacol146: 253-259
3.
Barbaran J.M., Aghajanian G.K. (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by α-adrenoceptor antagonists. Neuropharmacology19: 355-356
4.
Bayard J. (1957) The duration of tonic immobility in guinea pigs . J Comp Physiol Psychol50: 130-133
5.
Beckett S R G, Lawrence A.J., Marsden C.A., Marshall P.W. (1992) Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal grey. Psychopharmacology (in press)
6.
Birmelin I. (1990) Behaviour of pet animals. Dtsch Tierärztl Wochenschr97: 243-247
7.
Chopin P., Briley M. (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci8: 383-388
8.
Crespi F., Garratt J.C., Sleight A.J., Marsden C.A. (1990) In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism . Neuroscience35: 139-144
9.
Critchley M.A., Handley S.L. (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology86: 334-338
10.
Deacon R., Gardner C.R. (1986) Benzodiazepines and 5-HT ligands in a rat conflict test. Br J Pharmacol88: 330P
11.
Deakin J F W, Graeff F.G. (1991) 5-HT and mechanisms of defence. J Psychopharmacol5: 305-315
12.
De Vry J., Glaser T., Schuurmann T., Schreiber R., Traber J. (1991) 5-HT1A receptors in anxiety. In Briley M, File S E (eds), New concepts in anxiety. MacMillan Press, London, pp. 94-129
13.
Dunn R.W., Corbett R., Fielding S. (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol169: 1-10
14.
Engel J.A., Hjorth S., Svensson K., Carlsson A., Liljequist S. (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT). Eur J Pharmacol105: 365-368
15.
File S.E. (1992) Behavioural detection of anxiolytic action. In Elliott J M, Heal D J, Marsden C A (eds), Experimental approaches to anxiety and depression. John Wiley & Sons Ltd., pp. 25-44
16.
Goldberg H.L., Finnerty R.J. (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatr136: 1184-1187
17.
Graeff F.G., Schoenfeld R.I. (1970) Tryptamine mechanism in punished and nonpunished behaviour. J Pharmacol Exp Ther173: 277-283
18.
Haigler H.J., Aghajanian G.K. (1977) Serotonin receptors in the brain. Fed Proc36: 2159-2164
19.
Handley S.L., Mithani S. (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol327: 1-5
20.
Hoyer D., Middlemiss D.N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci10: 130-132
21.
Kostowski W., Plaznik A., Stefanski R. (1989) Intra-hippocampal buspirone in animal models of anxiety. Eur J Pharmacol168: 393-396
22.
Lawrence A.J., Marsden C.A. (1990) The effect of systemic 5-carboxamidotryptamine on extracellular levels of 5-HT in the freely moving guinea-pig. Br J Pharmacol101: 519P
23.
Lawrence A.J., Marsden C.A. (1992) Terminal autoreceptor control of 5-hydroxytryptamine as measured by in vivo microdialysis in the conscious guinea-pig. J Neurochem58: 142-146
24.
Leysen JE, Awouters F., Kennis L., Laudron PW, Vandenberk J., Janssen P A J (1981) Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. Life Sci28: 1015-1022
25.
Lister R.G. (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology92: 180-185
26.
Mansbach R.S., Harrod C., Hoffmann S.M., Nader M.A., Lei Z., Witkin J.M., Barrett J.E. (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther246:114-120
27.
Marsden C.A. (1985) In vivo monitoring of pharmacological and physiological changes in endogenous serotonin release and metabolism. In Gree A R (ed.), Neuropharmacology of serotonin . Oxford University Press, Oxford , pp. 3-27
28.
Marsden C.A., Martin K.F., Routlege C., Brazell M.P., Maidment N.T. (1986) Application of intracerebral dialysis and in vivo voltammetry to pharmacological and physiological studies of amine neurotransmitters . Ann NY Acad Sci473: 106-125
29.
Martin K.F., Marsden C.A. (1986) In vivo voltammetry in the suprachiasmatic nucleus of the rat: effects of RU24969, methiothepin and ketanserin. Eur J Pharmacol121: 135-139
30.
Meert T.F., Colpaert F.C. (1986) The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds. Psychopharmacology88: 445-450
31.
Moser P.C., Tricklebank M.D., Middlemiss D.N., Mir A.K., Hibert M.F., Fozard J.R. (1990) Characterization of MDL 73005EF as a 5-HT 1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol99: 343-349
32.
Mundey M.K., Marsden C.A., Fletcher A. (1992) Identification of 5-HT1A receptors in the dorsal raphe nucleus of the guinea-pig. Neurosci Lett Suppl42: S33
33.
Pellow S., Chopin P., File S.E., Briley M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods14: 149-167
34.
Rössner W. (1965) Stereotaktischer Hirnatlas vom Meerschweinchen . Pallas Verlag, Lochham
35.
Sharp T., Bramwell S.R., Grahame-Smith D.G. (1989a) 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol96: 283-290
36.
Sharp T., Bramwell S.R., Hjorth S., Grahame-Smith D.G. (1989b) Pharmacological characterization of 8-OH-DPATinduced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis . Br J Pharmacol98: 989-997
37.
Smart JL, Adlard B P F (1974) A water-maze test of learning ability for guinea-pigs . Lab Anim8: 311-315
38.
Söderpalm B., Hjorth S., Engel J.A. (1989) Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav32: 259-265
39.
Stein L., Wise D., Berger B.D. (1973) Anti-anxiety action of benzodiazepines: decrease in activity of serotonin neurons in the punishment system. In Garattini S, Massini E, Randall L O (eds), The benzodiazepines. Raven, New York, pp 299-326
Ungerstedt U., Herrera-Marschitz M., Jungnelius U., Stahle L., Tossman U., Zetterstrom T. (1982) Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis. Adv Biosci37: 219-231
43.
Waeber C., Schoeffter P., Palacios J.M., Hoyer D. (1989) 5-HT1D receptors in guinea pig and pidgeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol340: 486-494
44.
Wise C.D., Berger B.D., Stein L. (1972) Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the rat brain. Science177: 180-183
45.
Wright I. K (1991) 5-HT function in rodent models of anxiety. PhD. Thesis, Nottingham University, pp. 76-86
46.
Wright I.K., Upton N., Marsden C.A. (1991) Effect of potential anxiolytics on extracellular 5-HT in the ventral hippocampus observed of rats on the elevated x-maze using in vivo microdialysis. In Rollema H, Westerink B H C, Drijfhout W J (eds), Monitoring molecules in neuroscience. University Centre for Pharmacy, Groningen , pp. 208-211
